Chinese Clinical Oncology

• 论著 • Previous Articles     Next Articles

The expression of ARID1B in triple negative breast cancer and its clinical significance

WANG Yifan, ZHANG Yanqiu, LI Yongfei, ZHANG Yanhong, YIN Yongmei.   

  1. Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2016-09-21 Revised:2016-11-14 Online:2017-01-30 Published:2017-01-30
  • Contact: YIN Yongmei

Abstract: ObjectiveTo investigate the expression levels of AT-rich interactive domain-containing protein 1B(ARID1B) in triple negative breast cancer(TNBC) and its clinical significance. Methods The expression status of ARID1B in TNBC, non-TNBC and adjacent normal tissues was detected by immunohistochemistry and the correlation between the expression levels and clinicopathological characteristics and prognosis in patients with TNBC was analyzed. Results ARID1B protein expression was higher in 150 breast cancer tissues as compared to 30 adjacent normal tissues(57.5% vs. 13.3%, P<0.001). The positive expression rate of ARID1B in 90 TNBC and 30 non-TNBC group were 61.1%(55/90)and 33.3%(10/30), respectively, with a significant difference(P=0.007). The expression levels of ARID1B were remarkably associated with age, tumor size, histological grade and Ki-67 index(P<0.05), while not related to lymph node metastasis, TNM stage and the expression of p53(P>0.05) in TNBC. Particularly, compared to low-grade tumors, ARID1B displayed more bounteously expression in high-grade TNBC(P<0.001). The median overall survival(OS) time in TNBC patients with high ARID1B expression was 27.9 months(95%CI:25.1-30.8 months), lower than 49.1 months(95%CI:40.2-57.9 months)of TNBC patients with low ARID1B expression(P<0.05). Conclusion ARID1B is highly expressed in TNBC and its expression is significantly associated with age, tumor size, histological grade, Ki-67 index and survival, which might serve as a promising biomarker for TNBC prognostic evaluation and treatment.

No related articles found!
Viewed
Full text
293
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 293

  From Others local
  Times 12 281
  Rate 4% 96%

Abstract
128
Just accepted Online first Issue
0 0 128
  From Others
  Times 128
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!